Sunlight Active Drug Ingredients Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 31-07-2024
- Paid Up Capital ₹ 3.58 Cr
as on 31-07-2024
- Company Age 10 Year, 17 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 36.28 Cr
as on 31-07-2024
- Satisfied Charges ₹ 9.00 M
as on 31-07-2024
- Revenue 91.11%
(FY 2023)
- Profit -18.50%
(FY 2023)
- Ebitda 62.04%
(FY 2023)
- Net Worth 11.17%
(FY 2023)
- Total Assets 53.29%
(FY 2023)
About Sunlight Active Drug Ingredients
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.58 Cr.
The company currently has active open charges totaling ₹36.28 Cr. The company has closed loans amounting to ₹9.00 M, as per Ministry of Corporate Affairs (MCA) records.
Venkateswara Talupula and Sravya Talupula serve as directors at the Company.
- CIN/LLPIN
U24233TG2014PTC096658
- Company No.
096658
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Dec 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sunlight Active Drug Ingredients?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkateswara Talupula  | Managing Director | 03-Dec-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sravya Talupula | Director | 24-Jul-2015 | Current |
Financial Performance and Corporate Structure Insights of Sunlight Active Drug Ingredients.
Sunlight Active Drug Ingredients Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 91.11% increase. The company also saw a substantial fall in profitability, with a 18.5% decrease in profit. The company's net worth Soared by an impressive increase of 11.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunlight Active Drug Ingredients?
In 2023, Sunlight Active Drug Ingredients had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Guardinor Api Private LimitedActive 3 years 9 months
Venkateswara Talupula and Sravya Talupula are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Apr 2023 | ₹5.69 M | Open |
Others Creation Date: 06 Nov 2021 | ₹23.52 Cr | Open |
Others Creation Date: 29 Sep 2021 | ₹6.00 M | Open |
How Many Employees Work at Sunlight Active Drug Ingredients?
Sunlight Active Drug Ingredients has a workforce of 8 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunlight Active Drug Ingredients, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunlight Active Drug Ingredients's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
